Layilin augments integrin activation to promote antitumor immunity.

Saved in:
Bibliographic Details
Title: Layilin augments integrin activation to promote antitumor immunity.
Authors: Mahuron KM; Department of Surgery, University of California, San Francisco, San Francisco, CA., Moreau JM; Department of Dermatology, University of California, San Francisco, San Francisco, CA., Glasgow JE; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA., Boda DP; Department of Dermatology, University of California, San Francisco, San Francisco, CA., Pauli ML; Department of Dermatology, University of California, San Francisco, San Francisco, CA., Gouirand V; Department of Dermatology, University of California, San Francisco, San Francisco, CA., Panjabi L; Department of Dermatology, University of California, San Francisco, San Francisco, CA., Grewal R; Department of Dermatology, University of California, San Francisco, San Francisco, CA., Luber JM; Department of Biomedical Informatics, Harvard Medical School, Boston, MA.; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA., Mathur AN; Department of Dermatology, University of California, San Francisco, San Francisco, CA.; T-REX Bio, Burlingame, CA., Feldman RM; T-REX Bio, Burlingame, CA., Shifrut E; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA., Mehta P; Department of Dermatology, University of California, San Francisco, San Francisco, CA., Lowe MM; Department of Dermatology, University of California, San Francisco, San Francisco, CA., Alvarado MD; Department of Surgery, University of California, San Francisco, San Francisco, CA., Marson A; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA.; Chan Zuckerberg Biohub, San Francisco, CA.; Parker Institute for Cancer Immunotherapy, San Francisco, CA., Singer M; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA.; Department of Immunology, Harvard Medical School, Boston, MA.; Dana-Farber Cancer Institute, Boston, MA., Wells J; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA., Jupp R; T-REX Bio, Burlingame, CA., Daud AI; Department of Medicine, University of California, San Francisco, San Francisco, CA., Rosenblum MD; Department of Dermatology, University of California, San Francisco, San Francisco, CA.
Source: The Journal of experimental medicine [J Exp Med] 2020 Sep 07; Vol. 217 (9).
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Rockefeller University Press Country of Publication: United States NLM ID: 2985109R Publication Model: Print Cited Medium: Internet ISSN: 1540-9538 (Electronic) Linking ISSN: 00221007 NLM ISO Abbreviation: J Exp Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1540-9538
DOI:10.1084/jem.20192080